⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
ALT-006193Pre-approval
ACE (AI-Cirrhosis-ECG) 2.0
Mayo Clinic · Sponsor
Regulatory Pipeline
✓
Proof of Concept✓
Development3
Clinical Trial4
Pre-submission5
Submitted6
Under Review7
ClearedAll identifiers (2)
Aletia (canonical)
ALT-006193ClinicalTrials.gov (primary)
NCT05782283Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Mayo Clinic, you can claim this listing to add funding, team, and contact details.
Claim this listing →Clinical Trial Signal
NCT05782283 ↗
completed
Early Detection of Advanced Liver Disease Via Artificial Intelligence-Enabled Electrocardiogram (Advance): A Pragmatic, Cluster-Randomized Clinical Trial
Phase: na279 enrolledUS
Investor Interest
Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.
0
investors